A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu ...

A detailed look at four antiviral drugs available for the prevention and treatment of influenza infections. News & Perspective Drugs & Diseases ...

Background The large-scale deployment of antiviral drugs from the Strategic National Stockpile during the 2009 H1N1 influenza response provides a unique opportunity to study local public health ...

Pneumagen has announced the publication of phase 2 data showing its antiviral therapy, Neumifil, significantly reduced ...

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and ...

The antiviral baloxavir significantly reduced household transmission of influenza compared with placebo. The drug showed consistent effects across age groups, virus types, and countries, with no ...

Cidara Therapeutics has reported encouraging top-line outcomes from the Phase IIb NAVIGATE trial of the investigational ...

The likelihood of antiviral prescribing and dispensing among patients with influenza varied by care setting, patient age, and underlying medical conditions.

Influenza A (H1N1)pdm09 virus resistance to baloxavir, oseltamivir and sialic acid mimetics in single and dual therapies: Insights from human airway epithelia and murine models. Antiviral Res. 2025 ...

Assess your risk of contracting H1N1 swine flu with our easy-to-use Swine Flu Risk Calculator. Identify risk factors, ...

A 41-year-old woman from northwestern Cambodia's Siem Reap province has been confirmed for H5N1 human avian influenza, ...